| NATERA INC. DL-,0001 |
| USA |
| Gesundheit |
| US6323071042 / A14VPJ |
| 45E (Frankfurt) / NTRA (NASDAQ) |
| FRA:45E, ETR:45E, 45E:GR, NASDAQ:NTRA |
| - |
| https://www.natera.com/ |
|
Natera Inc. is a diagnostics company specializing in advanced genetic testing services for patients, clinicians, and healthcare systems. The company focuses on analyzing cell-free DNA to support clinical decision-making across several key areas of me..
>Volltext.. |
| 32460.8 Mio. EUR |
| 31727.94 Mio. EUR |
| 2196.85 Mio. EUR |
| -233.55 Mio. EUR |
| -198.8 Mio. EUR |
| -1.44 EUR |
| 210.89 Mio. EUR |
| 955.66 Mio. EUR |
| 185.36 Mio. EUR |
| 1.95 |
| 27.9% |
| -11.67% |
| - |
| - |
| - |
| 5 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 6.075.845 Euro. |
| NATERA |
| 30.07.26 |
|